Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide in CLL Patients With History of NMSC
NCT04844528Phase 2Recruiting
- Sponsor
- University of Utah
- Start
- Feb 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide in non-melanoma skin cancer (NMSC), sponsored by University of Utah. Started Feb 2022; status: recruiting.
02
Drugs
nicotinamide
03
Conditions
non-melanoma skin cancer (NMSC)
Beyond the preview
Go deeper on NCT04844528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04844528.